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SUMMARY. Glioblastoma is one of the most malignant brain tumors. Current treatments for glioblastoma
usually make poor responses, and novel treatment strategies are extremely imperative. Cytochalasin E
was reported to inhibit angiogenesis and tumor growth in some studies, but its effects on gliomas are still
unknown. In this study, we found cytochalasin E inhibits U87 human glioblastoma cell growth in a very
low concentration range of 10–8 to 10–6 M in a time and concentration dependent manner, and the IC50
were 1.17 ± 0.32 × 10–7 M for 48 h treatment, 6.65 ± 1.12 × 10–8 M for 72 h and 3.78 ± 1.30 × 10–8 M for 96
h. We also found cytochalasin E induces cell-cycle G2/M phase arrest (72 h-treatment of 10–6 M cytocha-
lasin E caused 56.2 ± 6.1 % cells arrest in G2/M phase) and cell apoptosis (96 h-treatment of 10–6 M cy-
tochalasin E induced 24.1 ± 4.2 % cells apoptosis). Thus, cytochalasin E is proposed as a potential agent
for glioblastoma chemotherapy.
